Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02319018
Title Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

gastrointestinal system cancer

Therapies

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Alisertib

Age Groups: adult
Covered Countries USA


No variant requirements are available.